Blog Posts

DOSE OF REALITY: NEW ANALYSIS UNDERSCORES HOW OFTEN BIG PHARMA’S PATENTS ARE UNRELATED TO CLINICAL INNOVATION

Jan 19, 2022

Study Finds Just Six Percent of Drug Patents in Infringement Suits Were for Read More

SECOND OPINION: BIG PHARMA CEO CLAIMS “COURAGEOUS” TO PRICE UNPROVEN TREATMENT 10 TIMES ESTIMATE OF FAIR PRICE

Jan 11, 2022

Biogen Decision to Change Aduhelm Price After Public Outcry Demonstrates Big Read More

BIG PHARMA WATCH: BIG PHARMA’S JANUARY PRICE HIKES CLIMB TO 588

Jan 7, 2022

Brand Name Drug Companies’ Business-as-Usual Approach to Price Increases Read More

DOSE OF REALITY: BIG PHARMA’S YEAR OF BAD BEHAVIOR — PART I

Dec 28, 2021

Part I: Price-Gouging An Unproven Treatment, Setting Out-of-Control Launch Read More

DOSE OF REALITY: BIG PHARMA’S YEAR OF BAD BEHAVIOR — PART II

Dec 28, 2021

Part II: Pushing Debunked Innovation Rhetoric to Oppose Rx Solutions Despite Read More

DOSE OF REALITY: BIG PHARMA’S YEAR OF BAD BEHAVIOR — PART III

Dec 28, 2021

Part III: Big Pharma Maintains Price-Hiking, Patent-Gaming Business-As-Usual Read More

DOSE OF REALITY: OVERSIGHT REPORT EXPOSES BIG PHARMA’S EGREGIOUS PRICING & ANTI-COMPETITIVE TACTICS — DEBUNKS INNOVATION RHETORIC

Dec 12, 2021

Investigation Finds Big Pharma Hiked Prices More Than 250 Times On Just 12 Top Read More

SECOND OPINION: BIG PHARMA DOUBLES DOWN ON BLAME GAME STRATEGY AMID UNPRECEDENTED MOMENTUM TO LOWER RX PRICES

Dec 3, 2021

New PhRMA Ad Campaign Aims to Dodge Accountability, Push Pharma-Backed Rebate Read More

BIG PHARMA WATCH: UNJUSTIFIED PRICE HIKES ON JUST SEVEN BRAND NAME DRUGS COST U.S. $1.6 BILLION IN 2020

Nov 16, 2021

New Analysis Underscores How Big Pharma’s Price Increases Cost The American Read More

BIG PHARMA EARNINGS WATCH: ASTRAZENECA

Nov 15, 2021

AstraZeneca’s Q3 Earnings Report Shows Pandemic Price Hikes Profitable for Read More

BIG PHARMA EARNINGS WATCH: SANOFI, ABBVIE, PFIZER & AMGEN

Nov 9, 2021

New Round of Q3 Earnings Reports Continue to Show Big Pharma Profits Buoyed By Read More

BIG PHARMA WATCH: BIG PHARMA SPENDS $263M ON LOBBYING, CAMPAIGN DONATIONS FIGHTING SOLUTIONS TO LOWER RX PRICES

Nov 4, 2021

New Analysis Highlights How Big Pharma Uses Limitless Resources Read More